HBA1C Analyzers Market to Record Significant Rise in Revenue Share

Posted by Merin John on May 19th, 2021

Persistence Market Research, in its report entitled “The HBA1C Analyzers Market”, paves the way for every technological advancement through which the healthcare industry is evolving. While preparing the report, every parameter has been considered – right from the inception of that particular thing in healthcare industry to the end-results and the role modern-day research and technology play therein.

The increasing prevalence of diabetes remains a key factor fueling HbA1c sales globally. Increasing geriatric population and the different advantages of HbA1c analyzers over fasting plasma glucose measurements, are also expected to increase the growth of the Hba1c analyzers market. Global sales are likely to reach approximately US$ 2 Bn by the end of 2029, according to a new study by Persistence Market Research (PMR).

Apart from factors driving the growth of the HbA1c analyzers market, there are few factors that are likely to restrain the growth of the HbA1c analyzer market. The poor availability of HbA1c analyzers and lack of awareness regarding HbA1c analyzers in some of the developing regions is expected to hinder the growth of HbA1c analyzers market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/29293

Company Profiles:

Abbott

ApexBio

ARKRAY, Inc.

Bio-Rad Laboratories, Inc.

Convergent Technologies GmbH & Co. KG

EKF Diagnostics

Erba Mannheim

F. Hoffmann-La Roche Ltd

HemoCue AB

i-SENS, Inc.

labONE, Inc.

LITE-ON TECHNOLOGY CORPORATION

Meril Life Sciences Pvt. Ltd.

OSANG Healthcare

TaiDoc Technology Corporation

Tosoh Corporation

Trinity Biotech

Zivak Technologies USA

Moreover, the presence of different variants, such as genetic variants, Elevated Fetal Hemoglobin (HbF), and chemically modified derivatives of hemoglobin, can affect the accuracy of HbA1c analyzers.

Increasing per capita healthcare expenditure is one of the main macroeconomic factors that enable people to opt for the appropriate method for the diagnosis of diseases. Changes in the structure of the economy and the availability of technologically advanced HbA1c analyzers are also among factors significantly contributing to the growth of the HbA1c analyzers market.

However, various other dynamics, such as favorable government regulations & reimbursement, increasing healthcare awareness, increasing adoption of HbA1c analyzers, etc., are expected to fuel the growth of the HaA1c analyzers market.

Several key manufacturers are focusing on mergers and acquisitions. For example, in September 2017, Abbott completed the acquisition of Alere, Inc. In July 2017, Abbott and Bigfoot Biomedical signed an agreement to commercialize diabetes management systems. Moreover, key players operating in the HbA1c market are involved in new product development.